Literature DB >> 15941053

Integration of supercritical fluid chromatography into drug discovery as a routine support tool. II. investigation and evaluation of supercritical fluid chromatography for achiral batch purification.

Craig White1, John Burnett.   

Abstract

Supercritical fluid chromatography (SFC) has recently been implemented within our analytical technologies department as a purity assessment and purification tool to complement HPLC for isomer and chiral separations. This report extends the previous work to achiral analysis and purification. This internal evaluation explores the potential impact SFC can have on high throughput, batch purification. Achiral methods have been optimised and batches of compounds purified using a retention time mapping strategy. Here the preparative retention time is predicted from a standard calibration curve and fraction windows set to ensure the peak of interest is collected in one of the four available fraction positions. In this contribution, a completely indirect scale up strategy is applied using totally independent analytical and preparative methods. This novel approach allows for fast analytical purity analysis without compromising the ability to scale up to the preparative system. The benefits and limitations of SFC for batch purification are described in comparison to HPLC across a set of standard compounds and a set of 90 research compounds.

Mesh:

Substances:

Year:  2005        PMID: 15941053     DOI: 10.1016/j.chroma.2005.02.087

Source DB:  PubMed          Journal:  J Chromatogr A        ISSN: 0021-9673            Impact factor:   4.759


  1 in total

1.  Probes for narcotic receptor mediated phenomena. 43. Synthesis of the ortho-a and para-a, and improved synthesis and optical resolution of the ortho-b and para-b oxide-bridged phenylmorphans: compounds with moderate to low opioid-receptor affinity.

Authors:  Feng Li; John E Folk; Kejun Cheng; Muneaki Kurimura; Jason A Deck; Jeffrey R Deschamps; Richard B Rothman; Christina M Dersch; Arthur E Jacobson; Kenner C Rice
Journal:  Bioorg Med Chem       Date:  2011-05-24       Impact factor: 3.641

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.